Skip to main content

Loxapine Tablets Shortage

Last Updated: June 15, 2022
Status: Current

Products Affected - Description
    • Loxapine oral tablet, Mylan Institutional, 10 mg, bottle, tablet 100 count, NDC 00378-7010-01 - discontinued
    • Loxapine oral tablet, Mylan Institutional, 25 mg, bottle, tablet 100 count, NDC 00378-7025-01 - discontinued
    • Loxapine oral tablet, Mylan Institutional, 5 mg, bottle, tablet 100 count, NDC 00378-7005-01 - discontinued
    • Loxapine oral tablet, Mylan Institutional, 50 mg, bottle, tablet 100 count, NDC 00378-7050-01 - discontinued
    • Loxapine oral tablet, Teva, 10 mg, bottle, tablet 100 count, NDC 00591-0370-01
Reason for the Shortage
    • Teva has all but one presentation available.
    • Marlex has loxapine tablets available.
    • Lannett has loxapine tablets available.
    • Mylan Institutional discontinued loxapine tablets in June 2021.
Available Products
    • Loxapine oral tablet, Lannett, 10 mg, bottle, tablet 100 count, NDC 00527-1395-01
    • Loxapine oral tablet, Lannett, 25 mg, bottle, tablet 100 count, NDC 00527-1396-01
    • Loxapine oral tablet, Lannett, 5 mg, bottle, tablet 100 count, NDC 00527-1394-01
    • Loxapine oral tablet, Lannett, 50 mg, bottle, tablet 100 count, NDC 00527-1397-01
    • Loxapine oral tablet, Marlex, 10 mg, bottle, tablet 100 count, NDC 10135-0586-01
    • Loxapine oral tablet, Marlex, 25 mg, bottle, tablet 100 count, NDC 10135-0587-01
    • Loxapine oral tablet, Marlex, 5 mg, bottle, tablet 100 count, NDC 10135-0585-01
    • Loxapine oral tablet, Marlex, 50 mg, bottle, tablet 100 count, NDC 10135-0588-01
    • Loxapine oral tablet, Teva, 25 mg, bottle, tablet 100 count, NDC 00591-0371-01
    • Loxapine oral tablet, Teva, 5 mg, bottle, tablet 100 count, NDC 00591-0369-01
    • Loxapine oral tablet, Teva, 50 mg, bottle, tablet 100 count, NDC 00591-0372-01

Estimated Resupply Dates

    • Most presentations are available.

Updated

Updated June 15, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 12, 2019 by Rachael Freeman, PharmD, BCPS. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer